We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

48 hedge funds and large institutions have $240M invested in Autolus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22.89% more ownership

Funds ownership: 0% → 22.89% (+23%)

Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.09%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WIM
Woodford Investment Management
United Kingdom
+$42.1M
2
CAM
Cormorant Asset Management
Massachusetts
+$40.3M
3
Capital World Investors
Capital World Investors
California
+$29.1M
4
AI
Alphabet Inc
California
+$18.9M
5
AG
Artal Group
Luxembourg
+$13.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WIM
1
Woodford Investment Management
United Kingdom
$42.6M +$42.1M +1,591,743 New
CAM
2
Cormorant Asset Management
Massachusetts
$40.9M +$40.3M +1,525,587 New
Capital World Investors
3
Capital World Investors
California
$29.5M +$29.1M +1,100,000 New
AI
4
Alphabet Inc
California
$19.1M +$18.9M +714,072 New
AG
5
Artal Group
Luxembourg
$14.1M +$13.9M +525,000 New
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$13.4M +$13.2M +500,000 New
Fidelity International
7
Fidelity International
Bermuda
$11.6M +$11.4M +432,674 New
DM
8
Deerfield Management
New York
$6.7M +$6.61M +250,000 New
BBA
9
Baker Bros. Advisors
New York
$6.3M +$6.22M +235,294 New
PHS
10
PFM Health Sciences
California
$5.3M +$5.23M +197,874 New
SFM
11
Sphera Funds Management
Israel
$4.72M +$4.65M +176,045 New
ACM
12
Aquilo Capital Management
California
$4.02M +$3.96M +150,000 New
Millennium Management
13
Millennium Management
New York
$3.91M +$3.86M +145,945 New
MIM
14
Monashee Investment Management
Massachusetts
$3.48M – – –
Alyeska Investment Group
15
Alyeska Investment Group
Illinois
$3.35M +$3.3M +125,000 New
Victory Capital Management
16
Victory Capital Management
Texas
$3.19M +$3.15M +119,020 New
Jennison Associates
17
Jennison Associates
New York
$3.17M +$3.12M +118,243 New
OAM
18
Oxford Asset Management
United Kingdom
$3.04M +$3.1M +117,320 New
GIM
19
Granahan Investment Management
Massachusetts
$2.61M +$2.57M +97,415 New
LCM
20
Laurion Capital Management
New York
$2.01M +$1.98M +75,000 New
DCM
21
Driehaus Capital Management
Illinois
$2M +$1.97M +74,649 New
ACH
22
ArrowMark Colorado Holdings
Colorado
$1.46M +$1.44M +54,400 New
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$1.34M +$1.32M +50,000 New
HIM
24
Hermes Investment Management
United Kingdom
$1.25M +$1.23M +46,600 New
WMSA
25
Weiss Multi-Strategy Advisers
New York
$1.1M +$1.09M +41,129 New
1
2

AUTL Hedge Fund Activity: Q2 2018 in Review

48 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q2 2018, worth a combined $240M.

Buyers outnumbered sellers: 48 funds opened new AUTL positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Woodford Investment Management, opening a new position worth an estimated $42.1M.

  • 48 institutional investors held Autolus Therapeutics (AUTL) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $240M of Autolus Therapeutics stock for Q2 2018.
  • 48 funds opened new Autolus Therapeutics positions in Q2 2018 and 0 closed out, a net change of +48 holders.
  • The largest Autolus Therapeutics buyer in Q2 2018 was Woodford Investment Management, an estimated $42.1M added.

Based on aggregated 13F filings for Q2 2018.